Boxer Capital’s Esperion Therapeutics ESPR Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2021
Q3 | – | Sell |
-500,000
| Closed | -$10.6M | – | 93 |
|
2021
Q2 | $10.6M | Hold |
500,000
| – | – | 0.37% | 63 |
|
2021
Q1 | $14M | Hold |
500,000
| – | – | 0.48% | 55 |
|
2020
Q4 | $13M | Sell |
500,000
-475,000
| -49% | -$12.4M | 0.42% | 52 |
|
2020
Q3 | $36.2M | Hold |
975,000
| – | – | 1.25% | 18 |
|
2020
Q2 | $50M | Hold |
975,000
| – | – | 2.2% | 11 |
|
2020
Q1 | $30.7M | Hold |
975,000
| – | – | 2.1% | 13 |
|
2019
Q4 | $58.1M | Hold |
975,000
| – | – | 3.29% | 9 |
|
2019
Q3 | $35.7M | Hold |
975,000
| – | – | 2.59% | 13 |
|
2019
Q2 | $45.4M | Hold |
975,000
| – | – | 3.9% | 7 |
|
2019
Q1 | $39.1M | Sell |
975,000
-225,000
| -19% | -$9.03M | 4.53% | 8 |
|
2018
Q4 | $55.2M | Sell |
1,200,000
-175,000
| -13% | -$8.05M | 6.82% | 7 |
|
2018
Q3 | $61M | Hold |
1,375,000
| – | – | 6.77% | 6 |
|
2018
Q2 | $53.9M | Buy |
1,375,000
+475,000
| +53% | +$18.6M | 6.1% | 7 |
|
2018
Q1 | $65.1M | Buy |
900,000
+100,000
| +13% | +$7.23M | 6.95% | 4 |
|
2017
Q4 | $52.7M | Buy |
800,000
+300,000
| +60% | +$19.8M | 9.63% | 4 |
|
2017
Q3 | $25.1M | Sell |
500,000
-500,000
| -50% | -$25.1M | 5.71% | 6 |
|
2017
Q2 | $46.3M | Sell |
1,000,000
-275,000
| -22% | -$12.7M | 11.01% | 3 |
|
2017
Q1 | $45M | Buy |
+1,275,000
| New | +$45M | 9.84% | 4 |
|